P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) - Grandclement, C.; Estoppey, C.; Dheilly, E.; Panagopoulou, M.; Martini, E.; Labanca, V.; De Angelis, S.; Frei, J.; Drake, A.; Rubod, A.; Gudi, G.; Udupa, V.; et al.